- Home
- HST vs PCVX Comparison
HST vs PCVX Comparison
Compare HST & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HST
- PCVX
- Stock Information
- Founded
- HST 1927
- PCVX 2013
- Country
- HST United States
- PCVX United States
- Employees
- HST N/A
- PCVX N/A
- Industry
- HST Real Estate Investment Trusts
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- HST Real Estate
- PCVX Health Care
- Exchange
- HST Nasdaq
- PCVX Nasdaq
- Market Cap
- HST 13.0B
- PCVX 13.2B
- IPO Year
- HST N/A
- PCVX 2020
- Fundamental
- Price
- HST $18.45
- PCVX $88.68
- Analyst Decision
- HST Buy
- PCVX Strong Buy
- Analyst Count
- HST 14
- PCVX 7
- Target Price
- HST $21.39
- PCVX $147.50
- AVG Volume (30 Days)
- HST 6.6M
- PCVX 1.1M
- Earning Date
- HST 11-06-2024
- PCVX 11-05-2024
- Dividend Yield
- HST 4.28%
- PCVX N/A
- EPS Growth
- HST N/A
- PCVX N/A
- EPS
- HST 1.02
- PCVX N/A
- Revenue
- HST $5,590,000,000.00
- PCVX N/A
- Revenue This Year
- HST N/A
- PCVX N/A
- Revenue Next Year
- HST $3.69
- PCVX N/A
- P/E Ratio
- HST $18.26
- PCVX N/A
- Revenue Growth
- HST 6.31
- PCVX N/A
- 52 Week Low
- HST $15.71
- PCVX $53.83
- 52 Week High
- HST $21.31
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- HST 58.92
- PCVX 41.78
- Support Level
- HST $18.45
- PCVX $86.80
- Resistance Level
- HST $19.03
- PCVX $92.94
- Average True Range (ATR)
- HST 0.38
- PCVX 3.22
- MACD
- HST -0.02
- PCVX 0.44
- Stochastic Oscillator
- HST 39.91
- PCVX 33.92
About HST Host Hotels & Resorts Inc.
Host Hotels & Resorts owns 81 predominantly urban and resort upper-upscale and luxury hotel properties representing over 43,000 rooms, mainly in the United States. Host recently sold off the company's interests in a joint venture owning a portfolio of hotels throughout Europe and also sold other joint ventures that owned properties in Asia and the United States. The majority of Host's portfolio operates under the Marriott and Starwood brands.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.